GMRE Share Price Performance
US$32.39
-10.96 (-25.28%)
331.9% overvalued intrinsic discount
US$7.50
Fair Value
Price US$32.39
AnalystLowTarget US$7.50
AnalystHighTarget US$11.52
AnalystConsensusTarget US$44.84
Fair ValueUS$7.50
Share Pricen/a
Global Medical REIT Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
GMRE Community Narratives
AN
Fair Value US$7.5 331.9% overvalued intrinsic discount
Debt Refinancing And Telehealth Shift Will Limit Future Value
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$11.52 181.1% overvalued intrinsic discount
Aging Population And Outpatient Shift Will Boost Medical Office Demand
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$44.84 27.8% undervalued intrinsic discount
Discounted Outpatient Properties Will Unlock Healthcare Real Estate Potential
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
Discounted Outpatient Properties Will Unlock Healthcare Real Estate Potential
Key Takeaways Acquisition of outpatient medical properties below market rates and successful re-tenanting are expected to drive rent, occupancy, and earnings growth. Favorable healthcare demographics and disciplined capital management are supporting stable demand, higher margins, and sustained long-term value creation.Read more
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
US$44.84
27.8% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
4.29% p.a.
Profit Margin
3.32%
Future PE
142.54x
Share price in 2028
US$56.82
Aging Population And Outpatient Shift Will Boost Medical Office Demand
Key Takeaways Strategic property acquisitions and strong tenant retention position the company for sustained rent and revenue growth well above current market expectations. Dividend redeployment and alternative funding avenues enhance earnings growth, acquisition capacity, and margin expansion without diluting shareholders.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$11.52
181.1% overvalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
8.39% p.a.
Profit Margin
6.11%
Future PE
94.13x
Share price in 2028
US$15.5
Debt Refinancing And Telehealth Shift Will Limit Future Value
Key Takeaways Higher refinancing costs and tenant consolidation risk threaten profitability and rental income stability amid a challenging interest rate and healthcare landscape. Legacy medical office assets face rising vacancies and CapEx demands, while asset recycling may dilute returns if market conditions worsen.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$7.5
331.9% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
3.18% p.a.
Profit Margin
3.73%
Future PE
116.51x
Share price in 2028
US$10.09
Snowflake Analysis
Global Medical REIT Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.25
- 99.89%
- -2.30%
- 140.3%
About GMRE
- Founded
- 2011
- Employees
- 26
- CEO
- WebsiteView website
Global Medical REIT Inc. (the “Company”) is a Maryland corporation and internally managed real estate investment trust (“REIT”) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. The Company holds its facilities and conducts its operations through a Delaware limited partnership subsidiary, Global Medical REIT L.P. (the “Operating Partnership”). The Company serves as the sole general partner of the Operating Partnership through a wholly owned subsidiary of the Company, Global Medical REIT GP LLC, a Delaware limited liability company. As of September 30, 2025, the Company was the 92.14% limited partner of the Operating Partnership, with an aggregate of 7.86% of the Operating Partnership owned by holders of long-term incentive plan units (“LTIP Units”) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for common limited partnership units (“OP Units”).
